Page last updated: 2024-11-12

monascorubrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

monascorubrin: isolated from Monascus species [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12118084
CHEMBL ID1215464
CHEBI ID156408
MeSH IDM0513473

Synonyms (20)

Synonym
CHEMBL1215464
monascorubrin
CHEBI:156408
(9ar)-9a-methyl-3-octanoyl-6-[(1e)-prop-1-en-1-yl]-2h-furo[3,2-g]isochromene-2,9(9ah)-dione
13283-90-4
monasred
(9ar)-9a-methyl-3-octanoyl-6-[(1e)-prop-1-en-1-yl]-2h-furo[3,2-g][2]benzopyran-2,9(9ah)-dione
prw98qj428 ,
ccris 7225
unii-prw98qj428
2h-furo(3,2-g)(2)benzopyran-2,9(9ah)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1-propenyl)-, (r-(e))-
(9ar)-9a-methyl-3-(1-oxooctyl)-6-(1e)-1-propen-1-yl-2h-furo(3,2-g)(2)benzopyran-2,9(9ah)-dione
2h-furo(3,2-g)(2)benzopyran-2,9(9ah)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1e)-1-propen-1-yl-, (9ar)-
(9ar)-9a-methyl-3-octanoyl-6-[(e)-prop-1-enyl]furo[3,2-g]isochromene-2,9-dione
Q27286726
2h-furo[3,2-g][2]benzopyran-2,9(9ah)-dione, 9a-methyl-3-(1-oxooctyl)-6-(1e)-1-propen-1-yl-, (9ar)-
CS-0144836
HY-N8492
DTXSID101037235
(r,e)-9a-methyl-3-octanoyl-6-(prop-1-en-1-yl)-2h-furo[3,2-g]isochromene-2,9(9ah)-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (6)

RoleDescription
food colouringA food additive that imparts colour to food. In European countries, E-numbers for permitted food colours are from E 100 to E 199, divided into yellows (E 100-109), oranges (E 110-119), reds (E 120-129), blues and violets (E 130-139), greens (E 140-149), browns and blacks (E 150-159), and others (E 160-199).
biological pigmentAn endogenous molecular entity that results in a colour of an organism as the consequence of the selective absorption of light.
fungal metaboliteAny eukaryotic metabolite produced during a metabolic reaction in fungi, the kingdom that includes microorganisms such as the yeasts and moulds.
Hsp90 inhibitorAn EC 3.6.4.10 (non-chaperonin molecular chaperone ATPase) inhibitor that blocks the action of heat shock protein 90.
anti-inflammatory agentAny compound that has anti-inflammatory effects.
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (5)

ClassDescription
azaphiloneAny member of a family of natural products which contains a 6H-isochromene-6,8(7H)-dione or an isoquinoline-6,8(2H,7H)-dione skeleton and its substituted derivatives thereof.
gamma-lactoneA lactone having a five-membered lactone ring.
triketoneA compound that contains three ketone functionalities.
polyketideNatural and synthetic compounds containing alternating carbonyl and methylene groups ('beta-polyketones'), biogenetically derived from repeated condensation of acetyl coenzyme A (via malonyl coenzyme A), and usually the compounds derived from them by further condensations, etc. Considered by many to be synonymous with the less frequently used terms acetogenins and ketides.
enoneAn alpha,beta-unsaturated ketone of general formula R(1)R(2)C=CR(3)-C(=O)R(4) (R(4) =/= H) in which the C=O function is conjugated to a C=C double bond at the alpha,beta position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID499312Binding affinity to HSP90 after 4 hrs by fluorescence polarization assay2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID499308Antiproliferative activity against human A431 cells after 72 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID499311Inhibition of yeast full-length recombinant HSP90 ATPase activity expressed in Escherichia coli strain BL21(DE3) assessed as inorganic phosphate release after 3 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID499310Antiproliferative activity against human IGROV1 cells after 72 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID499307Antiproliferative activity against human NCI-H460 cells after 72 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
AID499309Antiproliferative activity against human JR8 cells after 72 hrs2010Bioorganic & medicinal chemistry, Aug-15, Volume: 18, Issue:16
Natural and semisynthetic azaphilones as a new scaffold for Hsp90 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.16

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.16 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.46 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.16)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]